CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
WINTHER aims to develop new computational methods to predict the effectiveness of cancer therapies based on individual genetic profiles. This project seeks to improve patient outcomes by matching the right treatment to the right patient, thereby optimizing clinical trial efficiency.
Relevance:
WINTHER project focuses on the development and validation, in 24 months, of industry supported new tools and computational methods, to predict efficacy of drugs in cancer patientsCurrent medical needs:
Selection of cancer targeted therapies based on molecular abnormalities (mutations /amplifications/ translocations) benefit today only to 10-40% of patients.
For the remaining majority, therapeutic decision is still based according to decade-old protocols with limited efficacy.
Drug de…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
THE UNIVERSITY OF TEXAS SYSTEM
United States, Austin
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Israel, Ramat Gan
Type: Research institute
Activity type: Research Organisations
SME: No
Israel, Beer Sheva
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
